Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr. Reddy's Laboratories Limited    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: Vardhan

10/18/2020 | 12:03pm EST
FILE PHOTO: Small bottles labeled with a

NEW DELHI (Reuters) - Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said on Sunday.

Vardhan said the late stage trial generally involves thousands of participants, sometimes 30,000 to 40,000.

Of the vaccines currently in Phase 3 trials, all are administered by injection, according to the World Health Organization (WHO).

On Saturday, India's Dr Reddy's Laboratories Ltd and the Russian Direct Investment Fund (RDIF) said they have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine.

India's coronavirus infections rose by another 61,871 over the past 24 hours, data released on Sunday showed, although the health ministry said it is seeing a trend of steadily declining active cases.

The Indian Council of Medical Research (ICMR) said it will revisit its protocol for COVID-19 treatment after the WHO found some of the commonly used drugs, including remdesivir, had little or no impact on a patient's chances of surviving, local media reported earlier on Sunday.

(Reporting by Aditi Shah; Editing by Alexandra Hudson)


© Reuters 2020
All news about DR. REDDY'S LABORATORIES LIMITED
11/20DR REDDY LABORATORIES : Half yearly disclosure of related party transactions - S..
PU
11/17India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints
RE
11/16APPILI THERAPEUTICS : Reports Financial and Operational Results for Second Quart..
AQ
11/12DR REDDY LABORATORIES : Announces the Launch of Succinylcholine Chloride Injecti..
BU
11/12India's Serum says made 40 million doses of AstraZeneca's COVID vaccine, to m..
RE
11/09DR REDDY LABORATORIES : Presents Preclinical Data at SITC 2020 Demonstrating Sig..
BU
10/29DR REDDY LABORATORIES : Outcome of Board Meeting
PU
10/29DR REDDY LABORATORIES : . Reddy's partners with Department of Biotechnology - Bi..
BU
10/28DR REDDY LABORATORIES : India trials of Russian Sputnik-V vaccine may end as ear..
RE
10/28DR REDDY LABORATORIES : . Reddy's Names Parag Agarwal Chief Financial Officer
DJ
More news
Financials
Sales 2021 193 B 2 610 M 2 610 M
Net income 2021 27 597 M 374 M 374 M
Net cash 2021 10 068 M 136 M 136 M
P/E ratio 2021 29,6x
Yield 2021 0,52%
Capitalization 815 B 11 004 M 11 027 M
EV / Sales 2021 4,17x
EV / Sales 2022 3,63x
Nbr of Employees 21 650
Free-Float 68,2%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 5 522,33 INR
Last Close Price 4 910,95 INR
Spread / Highest target 30,3%
Spread / Average Target 12,4%
Spread / Lowest Target -18,5%
EPS Revisions
Managers
NameTitle
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED70.69%11 004
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-6.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273